Abstract:In this work, a multifunctional nanotheranostic agent FePDA/DOX@HA-CYS-TTDPP was constructed for photo/chemodynamic/chemo synergistic therapy guided by tumor-targeting fluorescence/photoacoustic dual-mode imaging. The diketopyrrolopyrrole (DPP) derivative (TTDPP) with near-infrared (NIR) absorption was coupled with tumor-targeting biomolecule hyaluronic acid (HA) via cystamine (CYS) to obtain the amphiphilic polymer HA-CYS-TTDPP. It was then self-assembled with Fe3+-coordinated 3+-coordinated polydopamine nanoparticles (FePDA) and anti-tumor drug doxorubicin (DOX) to form this nanomaterial. Its photothermal conversion efficiency reached 65.6% and it showed good photoacoustic performance, which can be attributed to the excellent photothermal conversion performance of TTDPP and PDA. TTDPP was a D-pi-A-pi-D type DPP derivative formed by the electron acceptor (A) DPP, the electron donor (D) triphenylamine, and the conjugated bridge thiophene, which exhibited excellent photothermal and photoacoustic performance, and a certain degree of photodynamic effect. PDA was formed by dopamine oxidation self-polymerization, which showed the advantages of good biocompatibility, high photothermal conversion efficiency, and easy functionalization; moreover, due to the d-d transition of exogenous Fe3+ 3+ in FePDA, the photothermal effect of PDA can be further enhanced. Furthermore, the weak acidity of tumor microenvironment (TME) facilitated the dissolution and release of DOX, and the overexpressed hyaluronidase (HAase) and glutathione (GSH) in tumor cells can also trigger the degradation of HA and the cleavage of disulfide bonds in CYS, respectively, leading to the release of DOX. Thus, the distance between DOX and PDA and TTDPP was increased, and the fluorescence of DOX was recovered, thereby achieving TME-responsive fluorescence activation and controlled drug release, and the tumor-targeting effect was further enhanced. Therefore, this nanotheranostic agent can realize triple response to the weak acidity, overexpressed GSH and HAase of TME. On the other hand, Fe3+ 3+ can react with GSH and H2O2 2 O 2 in tumor cells to induce Fenton reaction, generating cytotoxic center dot OH and resulting in chemodynamic therapeutic performance. Cell experiments confirmed that FePDA/DOX@HA-CYS-TTDPP can intelligently respond to TME and achieve targeted fluorescence imaging, and effectively inhibit the proliferation of HeLa tumor cells through photo/chemodynamic/chemo synergistic therapy. This system provides new ideas for achieving precise and efficient tumor theranostics.

Cobalt-doped Hollow Polydopamine for Oxygen Generation and GSH Consumption Enhanced Chemo-Ptt Combined Cancer Therapy.

Polydopamine (Pda)-Activated Cobalt Sulfide Nanospheres Responsive to Tumor Microenvironment (TME) for Chemotherapeutic-Enhanced Photothermal Therapy

Hyaluronic Acid-Modified Gold-Polydopamine Complex Nanomedicine for Tumor-Targeting Drug Delivery and Chemo-Photothermal-Therapy Synergistic Therapy

GSH/HAase/pH Triple-responsive Nanotheranostic Agent for Synergistic Therapy Guided by Tumor-targeting Fluorescence/Photoacoustic Dual-mode Imaging

Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy

Oxygen-generating Hybrid Polymeric Nanoparticles with Encapsulated Doxorubicin and Chlorin E6 for Trimodal Imaging-Guided Combined Chemo-Photodynamic Therapy.

Fabrication of Poly Dopamine@poly (Lactic Acid-Co-Glycolic Acid) Nanohybrids for Cancer Therapy via a Triple Collaboration Strategy

Polydopamine Nanoparticles as a Versatile Molecular Loading Platform to Enable Imaging-guided Cancer Combination Therapy.

Dynamically PEGylated and Borate-Coordination-Polymer-Coated Polydopamine Nanoparticles for Synergetic Tumor-Targeted, Chemo-Photothermal Combination Therapy

Combined Chemo- and Photothermal Therapies of Non-Small Cell Lung Cancer Using Polydopamine/Au Hollow Nanospheres Loaded with Doxorubicin

Uniformly Sized Hollow Microspheres Loaded with Polydopamine Nanoparticles and Doxorubicin for Local Chemo-Photothermal Combination Therapy

Tumor Microenvironment-Activated Self-Charge-generable Metallosupramolecular Polymer Nanocapsules for Photoacoustic Imaging-Guided Targeted Synergistic Photothermal-Chemotherapy

Targeted Polydopamine Nanoparticles Enable Photoacoustic Imaging Guided Chemo-Photothermal Synergistic Therapy of Tumor

Biodegradable Hollow Polydopamine@manganese Dioxide as an Oxygen Self-Supplied Nanoplatform for Boosting Chemo-photodynamic Cancer Therapy

Mesoporous Polydopamine Nanoparticles with Co-Delivery Function for Overcoming Multidrug Resistance Via Synergistic Chemo-Photothermal Therapy.

Biodegradable polydopamine and tetrasulfide bond co-doped hollowed mesoporous silica nanospheres as GSH-triggered nanosystem for synergistic chemo-photothermal therapy of breast cancer

An Enzyme-responsive Porphyrin Metal-organic Framework Nanosystem for Targeted and Enhanced Synergistic Cancer Photo-chemo Therapy

Tumor-targeted delivery of hyaluronic acid/polydopamine-coated Fe2+-doped nano-scaled metal-organic frameworks with doxorubicin payload for glutathione depletion-amplified chemodynamic-chemo cancer therapy

Hyaluronic Acid Conjugated Polydopamine Functionalized Mesoporous Silica Nanoparticles for Synergistic Targeted Chemo-Photothermal Therapy

Acidity/hydrogen peroxide-responsive PEGylated chitosan-modified polydopamine nanoparticles to realize effective photothermal conversion and intracellular drug delivery

Tumor Microenvironment-Responsive Polydopamine-Based Core/shell Nanoplatform for Synergetic Theranostics.